FDA au­tho­rizes ado­les­cent use of Omi­cron-spe­cif­ic boost­ers

Bi­va­lent boost­er shots spe­cif­ic to cur­rent­ly cir­cu­lat­ing Omi­cron strains will soon be avail­able to chil­dren as young as 5 years old.

The FDA has au­tho­rized …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER